ADIPOQ and type 2 diabetes mellitus: The adiponectin level was significantly increased by the addition of exenatide (0.39 ± 0.32 vs. −1.62 ± 0.97 μg/mL in exenatide and placebo groups, respectively, p = 0.045) in patients with poorly controlled type 2 diabetes [164].